Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 56 min ago
Peer-reviewedCC BY-NC-ND 4.0BMC Pediatrics

Weaning critically ill children undergoing prolonged sedation: challenges in achieving standardized practice

  1. 1Department of Emergency and Critical Care, Anesthesia and Pediatric Intensive Care Unit, Meyer Children’s Hospital, IRCCS, Florence, Italy
  2. 2Department of Health Science, Section of Anesthesia and Intensive Care, University of Florence, Piazza di San Marco 4, Florence, Italy

Abstract

Introduction: The aim of this study was to observe how drug dose reduction and interruption is conducted in critically ill children receiving sedation for longer than 5 days, analyzed as drug dose percentage modifications relative to the first day of weaning. We also assessed adherence to a predefined tapering target between 10 and 20% of the initial sedative dose.

Methods: Retrospective cohort study in a tertiary pediatric intensive care unit (PICU).

Results: Overall, 41 patients were enrolled. The cohort median (interquartile range) daily percentage reductions during the weaning phase were 10.6% (3.8–20.4) for fentanyl, 3.3% (0–13.7) for midazolam, 0% (0–10.7) for dexmedetomidine, 5.4% (0–15.4) for ketamine, and 10.5% (0–20.0) for propofol. Median reductions were significantly lower from the 20% target for midazolam, dexmedetomidine, ketamine, and propofol, while fentanyl showed a borderline difference. Adherence to the scheduled tapering range (10–20%) was low across all sedatives during weaning phase. Fentanyl had the highest proportion of weaning days within the target range (19.8%). Overall, only 16 (39%) patients had Withdrawal Assessment Tool 1 (WAT-1) data. Of these, 8 (50%) were positive on the first day of evaluation and three (18%) on the last day.

Conclusion: In children sedated for more than 5 days the recommended weaning rate was rarely respected. Withdrawal monitoring was suboptimal and did not guide drug weaning.

Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s12887-026-07545-4.

Related

  1. Tazemetostat combined PD-1 inhibitor achieving prolonged survival in primary proximal epithelioid sarcoma: a case report and review of the literature.
    Wei Li, Chenlu Zhang, Yang You +3
    Journal of medical case reportsPeer-reviewedCC BYFull textGeneral medicineEurope PMCPMC
  2. Cefepime exposure in prolonged or intermittent infusion in critically ill children
    Marc Hobeika, Deborah Hirt, Emmanuelle Bille +10
    British Journal of Clinical PharmacologyPeer-reviewedCC BY-NC-NDFull text1 citedGeneral biologyObstetrics, gynaecology & paediatricsHAL
  3. Opportunities and Challenges to Achieving the Australian Cancer Plan Goal of World Class Health Systems for Optimal Cancer Care
    Carolyn Ee, Ria Joseph, Elise Button +15
    The Medical Journal of AustraliaPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  4. A nurse-led standardized bedside gastric ultrasound monitoring protocol for abdominal distension management in critically ill patients receiving enteral nutrition: a pragmatic, exploratory randomized controlled trial.
    Panpan Han, Ruxin Jiang, Huiyi Zhang
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMCPMC
  5. Exploratory clinical predictors of prolonged hospital stay in patients with patent foramen ovale undergoing transthoracic echocardiography- or X-ray-guided closure
    Peng Zhang, Meng Chen, Xinhuan Dang +6
    MedicinePeer-reviewedCC BYFull textGeneral medicineEurope PMCPMCEurope PMC
BibTeX
@article{colosimo2026weaning,
  title = {{Weaning critically ill children undergoing prolonged sedation: challenges in achieving standardized practice}},
  author = {Denise Colosimo and Diletta Bindi and Diletta Mannini and Edoardo Piombino and Zaccaria Ricci},
  journal = {BMC Pediatrics},
  year = {2026},
  month = aug,
  doi = {10.1186/s12887-026-07545-4},
  url = {https://doi.org/10.1186/s12887-026-07545-4},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Weaning critically ill children undergoing prolonged sedation: challenges in achieving standardized practice
AU  - Denise Colosimo
AU  - Diletta Bindi
AU  - Diletta Mannini
AU  - Edoardo Piombino
AU  - Zaccaria Ricci
PY  - 2026
DA  - 2026/08/15
JO  - BMC Pediatrics
DO  - 10.1186/s12887-026-07545-4
UR  - https://doi.org/10.1186/s12887-026-07545-4
AB  - Introduction: The aim of this study was to observe how drug dose reduction and interruption is conducted in critically ill children receiving sedation for longer than 5 days, analyzed as drug dose percentage modifications relative to the first day of weaning. We also assessed adherence to a predefined tapering target between 10 and 20% of the initial sedative dose.  Methods: Retrospective cohort study in a tertiary pediatric intensive care unit (PICU).  Results: Overall, 41 patients were enrolled. The cohort median (interquartile range) daily percentage reductions during the weaning phase were 10.6% (3.8–20.4) for fentanyl, 3.3% (0–13.7) for midazolam, 0% (0–10.7) for dexmedetomidine, 5.4% (0–15.4) for ketamine, and 10.5% (0–20.0) for propofol. Median reductions were significantly lower from the 20% target for midazolam, dexmedetomidine, ketamine, and propofol, while fentanyl showed a borderline difference. Adherence to the scheduled tapering range (10–20%) was low across all sedatives during weaning phase. Fentanyl had the highest proportion of weaning days within the target range (19.8%). Overall, only 16 (39%) patients had Withdrawal Assessment Tool 1 (WAT-1) data. Of these, 8 (50%) were positive on the first day of evaluation and three (18%) on the last day.  Conclusion: In children sedated for more than 5 days the recommended weaning rate was rarely respected. Withdrawal monitoring was suboptimal and did not guide drug weaning.  Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s12887-026-07545-4.
SN  - 1471-2431
ER  -